Simple summary Having a new and more precise definition of BrS, based on its
cardiomyopathic component, may be crucial to meliorate the current clinical management of …

Brugada syndrome (BrS) is a cardiac electrophysiological disease with unknown etiology,
associated with sudden cardiac death. Symptomatic patients are treated with implanted …

Aims This study aims to evaluate the prognostic impact of the arrhythmogenic substrate size
in symptomatic Brugada syndrome (BrS) as well as to validate the long-term safety and …

Background Despite historically being considered a channelopathy, subtle structural
changes have been reported in Brugada syndrome (BrS) on histopathology and cardiac …

The SCN5A gene encodes the alpha subunit of the cardiac sodium channel, which plays a
fundamental role in the generation and propagation of the action potential in the heart …

Peripartum Cardiomyopathy (PPCM) is a polymorphic myocardial disease occurring late
during pregnancy or early after delivery. While reduced systolic function and heart failure …

Brugada syndrome (BrS) is a controversial disease whose pathophysiology is still far from
being fully understood. Unlike other cardiological disorders, a definite etiology has not yet …

Abstract Aims In Brugada syndrome (BrS), with spontaneous or ajmaline-induced coved ST
elevation, epicardial electro-anatomic potential duration maps (epi-PDMs) were detected on …

Abstract Background In patients with Brugada syndrome, myocardial fibrosis can be
identified through epicardial biopsy or cardiac magnetic resonance (CMR) imaging with late …

Abstract Introduction The dST‐Tiso is a newly proposed electrocardiographic (ECG) marker
during Brugada (BrS) type I pattern, that predicts the likelihood of ventricular arrhythmia (VA) …